Skip to search formSkip to main contentSkip to account menu

entecavir Oral Tablet [Baraclude]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • Prescrire international
  • 2017
  • Corpus ID: 73434508
2017
2017
Background and objective Entecavir (ETV) is a standard of care for chronic hepatitis B (CHB). In a bioequivalence study, ETV from… 
2016
2016
  • J. Song, S. Kim, S. Hwang
  • The Korean journal of gastroenterology = Taehan…
  • 2016
  • Corpus ID: 42454257
Entecavir (Baraclude®) is an oral antiviral drug used for the treatment of HBV. Entecavir is a reverse transcriptase inhibitor… 
2014
2014
INTRODUCTION: [4-5] BARACLUDE® is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against… 
2013
2013
Entecavir (Baraclude®, Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients… 
2013
2013
Stable isotope-labeled [(13) C4 ]entecavir (1) was prepared in 11 steps. Commercially available [(13) C]guanidine hydrochloride… 
Review
2011
Review
2011
The oral deoxyguanosine nucleoside analogue entecavir (Baraclude®) has potent activity against hepatitis B virus (HBV) and a high… 
2009
2009
Review
2006
Review
2006
Entecavir (Baraclude) is a novel nucleoside analogue of 2'-deoxyguanosine whose intracellular triphosphate form inhibits…